River Road Asset Management’s Royalty Pharma RPRX Stock Holding History
Bought
Maintained
Sold
Other funds holding RPRX
River Road Asset Management's RPRX Position: Q3 2026 in Review
River Road Asset Management reduced its Royalty Pharma (RPRX) stake by 19% in Q3 2026, selling an estimated $4.3M and leaving 310,956 shares worth $18.1M. The position accounts for 0.22% of the portfolio, ranked #103.
River Road Asset Management first reported a position in RPRX in Q4 2023 and has held it in 12 quarters since. The position peaked at $21.5M in Q2 2026. 695 funds tracked by Wall St. Rank hold RPRX as of Q3 2026.
- River Road Asset Management held 310,956 shares of Royalty Pharma worth $18.1M as of Q3 2026.
- River Road Asset Management sold 72,883 Royalty Pharma shares in Q3 2026, an estimated $4.3M.
- Royalty Pharma made up 0.22% of River Road Asset Management's portfolio in Q3 2026, its #103 holding.
- River Road Asset Management first reported a position in Royalty Pharma in Q4 2023 and has held it in 12 quarters since.
- River Road Asset Management's Royalty Pharma position peaked at $21.5M in Q2 2026.
- 695 funds tracked by Wall St. Rank held Royalty Pharma as of Q3 2026.
Based on River Road Asset Management's 13F filing for Q3 2026, filed 10 Nov 2026.